Dupont Capital Management’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Dupont Capital Management’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-25,000	Closed	-$257K	–	1334
2022 Q4	$257K	Hold	25,000	–	–	0.01%	724
2022 Q3	$252K	Hold	25,000	–	–	0.02%	808
2022 Q2	$251K	Hold	25,000	–	–	0.01%	899
2022 Q1	$250K	Hold	25,000	–	–	0.01%	979
2021 Q4	$255K	Buy	+25,000	New	+$247K	0.01%	1028

Other funds holding IQMD

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Dupont Capital Management's IQMD Position: Q1 2023 in Review

Dupont Capital Management sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 25,000 shares — an estimated $257K sold.

Dupont Capital Management first reported a position in IQMD in Q4 2021 and held it in 5 quarters. The position peaked at $257K in Q4 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

Dupont Capital Management reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Dupont Capital Management sold 25,000 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $257K.
Dupont Capital Management first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 5 quarters.
Dupont Capital Management's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $257K in Q4 2022.
8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Dupont Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.